Share
1,213 Posts.
lightbulb Created with Sketch. 389
clock Created with Sketch.
30/04/22
12:26
Share
Originally posted by Portsmouth:
↑
When the vote turns out to be 'No' Pfizer, I am sure will be running the data on the shareholders registry - (probably already have) and should they come back with an increased offer - they will know exactly where to pitch a new offer to get it over the line. they will not wish to go through the process again only to get knocked back again - there would be credibility issues. for example - if the data shows (and remember the shareholders registry shows when shares were purchased and for what price) should the numbers crunch to say 20c VWAP I cannot imaging Pzifer (or anyone else) risking anything under the 'crunched' figure - indeed they may need to put a premium on this number. but also remember the buy in price for many shareholders was pre dilutions so the VWAP number is not a true reflection of shareholder break even ( however it it is dressed up) so it's a far more complex calculation than it appears
Expand
I don't agree that a 2nd offer would necessarily be the last. Eg Virtus Health are currently the subject of a biding war between 2 suitors, they are currently at round 4 from memory